jiangxi healthcare imp & exp c
Trade trend analysis
Number of Transactions Quantity Weight
Number of Transactions Quantity Weight
The above chart presents the market trend analysis for jiangxi healthcare imp & exp c from 2023 to 2024. By examining various dimensions such as transaction quantity, transaction weight, average price, and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability. As of 2024, the company has completed 2 transactions, with a transaction quantity of 0 and a transaction weight of 1600.
- Year Transactions Quantity Weight
- 2023 0 0 0
- 2024 2 0 1600
Bill of lading data
< 1/2 >- Trade date 2024/09/11 B/L No. ——
- Suppliers jiangxi healthcare imp & exp c Buyers essential drug co.ltd.
- POLs —— PODs chattogram
- Supply area China Purchas area Bangladesh
- Weight 800kg Amount 24368
- Hs code 29339900 Product tags pharmaceutical raw material,indomethacin
- Product description PHARMACEUTICAL RAW MATERIALS INDOMETHACIN, BP. Expand
- Trade date 2024/02/29 B/L No. ——
- Suppliers jiangxi healthcare imp & exp c Buyers essential drug co.ltd.
- POLs —— PODs dhaka
- Supply area China Purchas area Bangladesh
- Weight 800kg Amount 28368
- Hs code 29339900 Product tags indomethacin
- Product description INDOMETHACIN Expand
Partners
Total 1- Rank Company Transactions Per Detail
- 1 essential drug co.ltd. bangladeshbuyer,they trade on 2024-09-11 2 100.00% >
Products
Total 2- Products Transactions Per Detail
-
indomethacin
2 100% > -
pharmaceutical raw material
1 50% >
Hscode rank
Total 1- HSCode Name Transactions Per Detail
- HS 29339900 2 100% >
Trading Area
Total 1- Area Transactions Per Detail
- bangladesh 2 100.00% >